|
A new combination
test that screens hypertensive people for diabetes is just as
sensitive and a lot cheaper than the test currently recognized
as the gold standard in diabetes detection.
The
combination test measures both fasting blood sugar and glycosylated hemoglobin
levels.
In their study
reported in the April issue of the American Journal of Hypertension,
University of Vienna researchers compared the combination test
with the gold standard oral glucose tolerance test which is highly
sensitive in detecting even the most mild forms of diabetes.
The researchers
conducted their study at the hypertension unit of Vienna General
Hospital between January 1999 and July 2001. Combination and standard
tests were performed in 152 hypertensive patients to identify
those with diabetes.
The oral glucose tolerance test identified 33 patients as being
diabetic. The first of the two-step tests detected diabetes in
25 patients by measuring their fasting blood glucose levels. The
eight remaining patients were identified through the second-step
of the testing which involves measuring glycated hemoglobin levels.
The cost
of the oral glucose tolerance test was $73.38 per patient, compared
to $42.34 per patient for the two-step test.
"The
combined use of fasting plasma glucose and glycosylated hemoglobin identified
all diabetic patients and revealed no false negative results," concluded
the researchers. "Based on our study results, recommendations concerning
the screening of hypertensive patients should be reevaluated, as the combination
of fasting plasma glucose and glycosylated hemoglobin increased sensitivity of
both methods." Dr.
Michael A. Weber, an editor of the American Journal of Hypertension, said the
combination test would enable diabetic hypertensives to be identified early, enabling
physicians to select the correct drug therapy since these patients require different
medications than those with hypertension alone. American
Journal of Hypertension: April 2003; 16:297-301
|